A detailed history of Petredis Investment Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Petredis Investment Advisors LLC holds 80,111 shares of PFE stock, worth $2.11 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
80,111
Previous 79,792 0.4%
Holding current value
$2.11 Million
Previous $2.23 Billion 3.84%
% of portfolio
0.25%
Previous 0.25%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$27.7 - $31.39 $8,836 - $10,013
319 Added 0.4%
80,111 $2.32 Billion
Q2 2024

Jul 16, 2024

SELL
$25.26 - $29.6 $2,576 - $3,019
-102 Reduced 0.13%
79,792 $2.23 Billion
Q1 2024

Apr 25, 2024

BUY
$25.89 - $29.73 $53,877 - $61,868
2,081 Added 2.67%
79,894 $2.22 Billion
Q4 2023

May 20, 2024

BUY
$26.13 - $33.94 $113,064 - $146,858
4,327 Added 5.93%
77,243 $2.22 Billion
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $127,958 - $166,204
4,897 Added 6.72%
77,813 $2.24 Billion
Q3 2023

May 20, 2024

BUY
$32.09 - $37.51 $3,722 - $4,351
116 Added 0.16%
72,916 $2.42 Billion
Q3 2023

Nov 01, 2023

BUY
$32.09 - $37.51 $3,722 - $4,351
116 Added 0.16%
72,916 $2.42 Billion
Q2 2023

May 20, 2024

SELL
$36.12 - $41.79 $1,950 - $2,256
-54 Reduced 0.07%
72,800 $2.67 Billion
Q2 2023

Aug 07, 2023

SELL
$36.12 - $41.79 $1,950 - $2,256
-54 Reduced 0.07%
72,800 $2.67 Billion
Q1 2023

May 20, 2024

BUY
$39.39 - $51.28 $51,128 - $66,561
1,298 Added 1.81%
72,854 $2.97 Billion
Q1 2023

May 03, 2023

BUY
$39.39 - $51.28 $51,128 - $66,561
1,298 Added 1.81%
72,854 $2.97 Billion
Q4 2022

May 20, 2024

SELL
$41.75 - $54.5 $348,111 - $454,421
-8,338 Reduced 10.44%
71,556 $3.67 Billion
Q4 2022

Feb 06, 2023

BUY
$41.75 - $54.5 $2.99 Million - $3.9 Million
71,556 New
71,556 $3.67 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Petredis Investment Advisors LLC Portfolio

Follow Petredis Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Petredis Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Petredis Investment Advisors LLC with notifications on news.